Paul Yasurjak
7 statements · 1 topic
Featured statements
They reviewed patients enrolled in trials between 2007 and 2017 and found that the presence of segmental chromosomal abberations such as the loss or gain of a portion of the chromosomal arm can have a negative impact on patient outcomes.
quote ·
Neuroblastoma
The updated schema classifies tumors as high risk when there is no MYCN amplification but segmental chromosomal abnormalities are present
guideline ·
Neuroblastoma
Nothing matches these filters — clear the search or widen the filters.
Paul's statements about Neuroblastoma 7 statements
Open the Neuroblastoma collection →
Update Course Rewind: Staging and Management of Neuroblastoma 2022
Statement
The Children's Oncology Group neuroblastoma classification tree is constantly changing as new information is added
Open
Statement
Based on the 2021 COG classification, the presented tumor would be classified as higher risk
Open
Statement
The presence of segmental chromosomal aberrations such as loss or gain of a portion of the chromosomal arm can have a negative impact on patient outcomes
Open
Statement
The updated schema classifies tumors as high risk when there is no MYCN amplification but segmental chromosomal abnormalities are present
Open
Quotation
He shared a recently updated paper from the Children's Oncology Group showing that the neuroblastoma tree is constantly changing as we're adding new information.
Open
Quotation
They reviewed patients enrolled in trials between 2007 and 2017 and found that the presence of segmental chromosomal abberations such as the loss or gain of a portion of the chromosomal arm can have a negative impact on patient outcomes.
Open